Does prolidase indicate worsening of Hepatitis B infection?

dc.contributor.authorDuygu, Fazilet
dc.contributor.authorAksoy, Nurten
dc.contributor.authorÇiçek, Ayşegül Çopur
dc.contributor.authorBütün, İlknur
dc.contributor.authorÜnlü, Şebnem
dc.date.accessioned2020-12-19T20:04:06Z
dc.date.available2020-12-19T20:04:06Z
dc.date.issued2013
dc.departmentRTEÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü
dc.description.abstractBackground Hepatitis B infection is a health problem that affects more than 400 million people all over the world. We aimed to evaluate the usability of prolidase enzyme that plays an important role in collagen synthesis. Prolidase levels increase in hepatic damage, which can be used as diagnostic parameters in the progressions to chronic hepatitis B (CHB) infection by evaluating it in different clinical forms of hepatitis B infection. Methods A total of 69 patients who presented to our clinic with chronic hepatitis B (CHB) infection, 72 patients with inactive hepatitis B infection (IHB), and 45 healthy volunteers were included into this study. Alanine transaminase (ALT), Aspartate aminotransferase (AST) and prolidase levels of patients were measured. Hepatic biopsy was performed in patients with CHB infection. Prolidase levels were evaluated in three different groups, and its correlations with fibrosis were investigated. Results Prolidase was different between all groups (P < 0.001). Prolidase level was found to be higher in CHB and IHB compared to the control group. There was no correlation between this enzyme, fibrosis, and histological activity index. Conclusion in this present study, it is shown that prolidase levels increase in hepatitis B infection. It may be used as a biochemical marker in the chronic hepatitis B.
dc.identifier.citationDuygu, F., Aksoy, N., Cicek, A.C., Butun, I., Unlu, S. (2013). Does prolidase indicate worsening of Hepatitis B infection?. Journal of Clinical Laboratory Analysis, 27(5), 398-401. https://doi.org/10.1002/jcla.21617
dc.identifier.doi10.1002/jcla.21617
dc.identifier.endpage401
dc.identifier.issn0887-8013
dc.identifier.issn1098-2825
dc.identifier.issue5
dc.identifier.pmid24038226
dc.identifier.scopus2-s2.0-84884194196
dc.identifier.scopusqualityQ1
dc.identifier.startpage398
dc.identifier.urihttps://doi.org/10.1002/jcla.21617
dc.identifier.urihttps://hdl.handle.net/11436/3280
dc.identifier.volume27
dc.identifier.wosWOS:000324400000011
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorÇiçek, Ayşegül Çopur
dc.language.isoen
dc.publisherJohn Wiley & Sons Inc
dc.relation.ispartofJournal of Clinical Laboratory Analysis
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20201219
dc.subjectProlidase
dc.subjectChronic hepatitis B
dc.subjectInactive hepatitis B
dc.titleDoes prolidase indicate worsening of Hepatitis B infection?
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
duygu-2013.pdf
Boyut:
59.28 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Kapalı Erişim / Closed Access